Forbidden Drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Oxford [u.a.]
Oxford Univ. Press
2009
|
| Ausgabe: | 3. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | XVIII, 260 S. |
| ISBN: | 9780199559961 0199559961 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV035535871 | ||
| 003 | DE-604 | ||
| 005 | 20101129 | ||
| 007 | t | ||
| 008 | 090526s2009 |||| 00||| eng d | ||
| 020 | |a 9780199559961 |9 978-0-19-955996-1 | ||
| 020 | |a 0199559961 |9 0-19-955996-1 | ||
| 035 | |a (OCoLC)318415678 | ||
| 035 | |a (DE-599)BVBBV035535871 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 |a DE-355 | ||
| 050 | 0 | |a RC564.29 | |
| 082 | 0 | |a 362.29 |2 22 | |
| 084 | |a XI 5803 |0 (DE-625)153018:12909 |2 rvk | ||
| 084 | |a YH 3003 |0 (DE-625)153535:12909 |2 rvk | ||
| 245 | 1 | 0 | |a Forbidden Drugs |c [ed. by] Philip Robson |
| 250 | |a 3. ed. | ||
| 264 | 1 | |a Oxford [u.a.] |b Oxford Univ. Press |c 2009 | |
| 300 | |a XVIII, 260 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Psychotropic drugs |v Popular works | |
| 650 | 4 | |a Street Drugs | |
| 650 | 4 | |a Substance abuse |v Popular works | |
| 650 | 4 | |a Substance-Related Disorders | |
| 650 | 4 | |a Substance-Related Disorders |x etiology | |
| 650 | 0 | 7 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 0 | 1 | |a Drogenmissbrauch |0 (DE-588)4070587-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Robson, Philip |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-017592000 | ||
Datensatz im Suchindex
| _version_ | 1804139173525848064 |
|---|---|
| adam_text | Contents
Preface
to Third Edition
vii
Preface to Second Edition
ix
Preface to First Edition
xi
Contributors
xvii
1
Why use drugs?
1
The search for altered consciousness
5
Practical reasons for experimenting with drugs
б
Biological explanations
7
Psychological explanations
8
Family and cultural explanations
10
Risk taking
12
Is experimenting with drugs abnormal ?
13
2
The consequences of drag use
17
Visible and invisible drug users
18
Short-term consequences
20
Longer-term consequences
23
Influences upon the outcome of dependent drug use
25
3
Alcohol
31
Historical background
31
Preparation and distribution
36
Scientific information
37
Possible beneficial effects
39
Recreational use
40
Unwanted effects
41
Acute effects
42
Chronic effects
44
4
Tobacco
49
Preparation and distribution
51
Scientific information
52
Possible beneficial effects
54
Recreational use
54
Unwanted effects
56
Xiv CONTENTS
5
Cannabis
59
Historical
background
59
Preparation and distribution
65
Scientific information
66
Medical uses
68
Recreational use
69
Unwanted effects
72
6
Cocaine, amphetamines, and other stimulants SJ
Cocaine
81
Historical background SI
Preparation and distribution
83
Scientific information
84
Medical uses
85
Recreational use
85
Unwanted effects
88
Amphetamines
91
Historical background
91
Preparation and distribution
93
Scientific information
93
Medical uses
94
Recreational use
95
Unwanted effects
96
Other stimulants
97
Khat(orQat)
97
Benzylpiperazine
98
Pemolme
98
Appetite suppressants
99
7
Psychedelics and hallucinogens
101
Historical background
101
Preparation and distribution
108
Scientific information
110
Medical uses 111
Modern ritualistic use
112
Recreational use
112
Unwanted effects
116
8
The inhalants
121
Historical background
121
Preparations available
123
Scientific information
124
CONTENTS
xv
Recreaţional
use
124
Unwanted effects
126
9
Ecstasy and other party drugs
131
The club scene
131
Ecstasy
131
Historical background
131
Preparation and distribution
133
Scientific information
133
Medical uses
134
Recreational use
135
Unwanted effects
136
Gammahydroxybutyrate (GHB)
138
Gamma-butyrolactone (GBL) and
1,4-
butanediol (1,4-BD)
139
Ketamine
139
mCPP
140
10
Anabolic steroids
143
Historical background
143
Preparation and distribution
143
Scientific information
144
Medical uses
144
Recreational use
145
Unwanted effects
146
11
Tranquillizers and sleeping pffls
149
Barbiturates
149
Historical background
149
Preparation and distribution
150
Scientific information
150
Medical uses
151
Recreational use
151
Unwanted effects
152
Benzodiazepines
153
Historical background
153
Preparation and distribution
154
Scientific information
155
Medical uses
156
Recreational use
156
Unwanted effects
157
12
Heroin and the opioids
161
Historical background
161
XVi
CONTENTS
Preparation and distribution
168
Scientific information
170
Medical uses
171
Recreational use
172
Unwanted effects
175
13
The nature of addiction
181
Introduction
181
Neurobiological mechanisms
182
Psychological processes
187
Socio-cultural influences
192
Issues of personal morality
194
Conclusion
195
14
Helping problem drug users
197
Drugs and young people
197
Psychological treatments
—
general principles
200
Relapse, prevention and rehabilitation
202
Self-help groups
204
Specific strategies for smokers
206
Specific strategies for drinkers
207
Specific strategies for opioid users
210
Detoxification
211
Substitute or long-term prescribing
212
Specific strategies for amphetamine and cocaine users
214
Specific strategies for
cannabis
smokers
215
15
International drug policy
—
is it working?
22Í
How are drugs controlled?
221
Strategies aimed at reducing smoking
225
Strategies aimed at reducing drinking
226
Current policy approaches to illegal drugs
227
The war on drugs
228
Two invited appraisals of present and future US drug policy
230
1.
Robert
L
DuPont, M.D.
—
President, Institute for Behavior and
Health, Inc.
230
2.
Ethan
Nadelmann,
Ph.D.
—
Founder and Executive Director,
Drag Policy Alliance
234
UK drag policy: is a more radical approach needed?
239
Bibliography and Reports
247
Index
251
mm
mm,
earned
cftqpÈa
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV035535871 |
| callnumber-first | R - Medicine |
| callnumber-label | RC564 |
| callnumber-raw | RC564.29 |
| callnumber-search | RC564.29 |
| callnumber-sort | RC 3564.29 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 5803 YH 3003 |
| ctrlnum | (OCoLC)318415678 (DE-599)BVBBV035535871 |
| dewey-full | 362.29 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29 |
| dewey-search | 362.29 |
| dewey-sort | 3362.29 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie Medizin |
| edition | 3. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01916nam a2200469 c 4500</leader><controlfield tag="001">BV035535871</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20101129 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090526s2009 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199559961</subfield><subfield code="9">978-0-19-955996-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199559961</subfield><subfield code="9">0-19-955996-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)318415678</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035535871</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC564.29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.29</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5803</subfield><subfield code="0">(DE-625)153018:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 3003</subfield><subfield code="0">(DE-625)153535:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Forbidden Drugs</subfield><subfield code="c">[ed. by] Philip Robson</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a.]</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 260 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="v">Popular works</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Street Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance abuse</subfield><subfield code="v">Popular works</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Drogenmissbrauch</subfield><subfield code="0">(DE-588)4070587-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robson, Philip</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017592000</subfield></datafield></record></collection> |
| id | DE-604.BV035535871 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T21:39:52Z |
| institution | BVB |
| isbn | 9780199559961 0199559961 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017592000 |
| oclc_num | 318415678 |
| open_access_boolean | |
| owner | DE-29 DE-355 DE-BY-UBR |
| owner_facet | DE-29 DE-355 DE-BY-UBR |
| physical | XVIII, 260 S. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Oxford Univ. Press |
| record_format | marc |
| spelling | Forbidden Drugs [ed. by] Philip Robson 3. ed. Oxford [u.a.] Oxford Univ. Press 2009 XVIII, 260 S. txt rdacontent n rdamedia nc rdacarrier Psychotropic drugs Popular works Street Drugs Substance abuse Popular works Substance-Related Disorders Substance-Related Disorders etiology Drogenmissbrauch (DE-588)4070587-0 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s Drogenmissbrauch (DE-588)4070587-0 s DE-604 Robson, Philip Sonstige oth Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Forbidden Drugs Psychotropic drugs Popular works Street Drugs Substance abuse Popular works Substance-Related Disorders Substance-Related Disorders etiology Drogenmissbrauch (DE-588)4070587-0 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| subject_GND | (DE-588)4070587-0 (DE-588)4047729-0 |
| title | Forbidden Drugs |
| title_auth | Forbidden Drugs |
| title_exact_search | Forbidden Drugs |
| title_full | Forbidden Drugs [ed. by] Philip Robson |
| title_fullStr | Forbidden Drugs [ed. by] Philip Robson |
| title_full_unstemmed | Forbidden Drugs [ed. by] Philip Robson |
| title_short | Forbidden Drugs |
| title_sort | forbidden drugs |
| topic | Psychotropic drugs Popular works Street Drugs Substance abuse Popular works Substance-Related Disorders Substance-Related Disorders etiology Drogenmissbrauch (DE-588)4070587-0 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| topic_facet | Psychotropic drugs Popular works Street Drugs Substance abuse Popular works Substance-Related Disorders Substance-Related Disorders etiology Drogenmissbrauch Psychopharmakon |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017592000&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT robsonphilip forbiddendrugs |